Cullinan Therapeutics, Inc. (CGEM)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Cullinan Therapeutics, Inc. (CGEM)
Company Performance

Current Price

as of Oct 16, 2024

$17.61

P/E Ratio

N/A

Market Cap

$1.02B

Description

Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Metrics

Overview

  • HQCambridge, MA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerCGEM
  • Price$17.61+8.44%

Trading Information

  • Market Cap$1.02B
  • Float67.26%
  • Average Daily Volume (1m)601,760
  • Average Daily Volume (3m)603,194
  • EPS-$3.10

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$42.03M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$49.95M
  • EV$300.35M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B1.55
Documents